Bazedoxifene acetate is a third-generation selective estrogen receptor modulator (SERM) primarily used to treat osteoporosis in postmenopausal women by reducing bone loss and preventing vertebral fractures.… Read more
Bazedoxifene acetate is a third-generation selective estrogen receptor modulator (SERM) primarily used to treat osteoporosis in postmenopausal women by reducing bone loss and preventing vertebral fractures. By acting as an estrogen receptor antagonist in bone tissue, it helps maintain bone density. This category provides essential analytical tools, including the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These reference standards are vital for pharmaceutical laboratories conducting rigorous impurity profiling, method validation, and routine quality control of the drug substance. Utilizing these high-quality materials ensures precise quantification and identification of degradation products or synthesis-related impurities, supporting comprehensive regulatory compliance and the consistent assessment of drug efficacy and safety in analytical testing protocols.
![Chemical structure of 1-[4-(Benzyloxy)-3-bromophenyl]-2-bromopropan-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2512198-68-2-1-4-Benzyloxy-3-bromophenyl-2-bromopropan-1-one.png&w=3840&q=75)